Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2024 Filed Aug 5, 2024 18:57 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionCommon Stock | 17,857 | $1.64 | $29,303.34 |
DisclosureSEC source: 0001415889-24-020785 · form4-08052024_100803.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 18:57 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,476 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001415889-24-020785 · form4-08052024_100803.xml · derivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,858 Underlying: Common Stock · 15,476 shares Expires 2030-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F4 · derivative.exercise_date: The option has fully vested. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 18:57 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
SaleCommon Stock | 15,476 | $4.54 | $70,261.04 |
DisclosureSEC source: 0001415889-24-020785 · form4-08052024_100803.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.445 to $4.805, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 18:57 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionCommon Stock | 15,476 | $1.64 | $25,396.12 |
DisclosureSEC source: 0001415889-24-020785 · form4-08052024_100803.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 20:39 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-020343 · form4-07302024_080732.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,396 Underlying: Common Stock · 3,000 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 20:39 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 3,000 | $4.75 | $14,238.00 |
DisclosureSEC source: 0001415889-24-020343 · form4-07302024_080732.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.63 to $4.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 26, 2024 Filed Jul 30, 2024 20:39 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 3,000 | $2.93 | $8,778.00 |
DisclosureSEC source: 0001415889-24-020343 · form4-07302024_080732.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| July 09, 2024 Filed Jul 10, 2024 16:15 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,531 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001415889-24-019463 · form4-07102024_040702.xml · derivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 13,531 shares Expires 2030-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F4 · derivative.exercise_date: The option has fully vested. Read SEC document |
| July 09, 2024 Filed Jul 10, 2024 16:15 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
SaleCommon Stock | 13,531 | $4.03 | $54,584.05 |
DisclosureSEC source: 0001415889-24-019463 · form4-07102024_040702.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.105, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 09, 2024 Filed Jul 10, 2024 16:15 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionCommon Stock | 13,531 | $1.64 | $22,204.37 |
DisclosureSEC source: 0001415889-24-019463 · form4-07102024_040702.xml · nonDerivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 16:15 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,802 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001415889-24-019463 · form4-07102024_040702.xml · derivative · entry 5 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,865 Underlying: Common Stock · 19,802 shares Expires 2030-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F4 · derivative.exercise_date: The option has fully vested. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 16:15 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
SaleCommon Stock | 19,802 | $4.03 | $79,782.26 |
DisclosureSEC source: 0001415889-24-019463 · form4-07102024_040702.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.055, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 16:15 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionCommon Stock | 19,802 | $1.64 | $32,495.08 |
DisclosureSEC source: 0001415889-24-019463 · form4-07102024_040702.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 21:18 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,956 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-018635 · form4-07012024_090717.xml · derivative · entry 5 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,396 Underlying: Common Stock · 4,956 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 21:18 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,044 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001415889-24-018635 · form4-07012024_090717.xml · derivative · entry 4 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,121 Underlying: Common Stock · 5,044 shares Expires 2030-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 21:18 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 10,000 | $3.99 | $39,900.00 |
DisclosureSEC source: 0001415889-24-018635 · form4-07012024_090717.xml · nonDerivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.93 to $4.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 21:18 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 4,956 | $2.93 | $14,501.26 |
DisclosureSEC source: 0001415889-24-018635 · form4-07012024_090717.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 21:18 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 5,044 | $1.64 | $8,277.20 |
DisclosureSEC source: 0001415889-24-018635 · form4-07012024_090717.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 16:17 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 33,333 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001415889-24-017956 · form4-06242024_080648.xml · derivative · entry 3 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock · 33,333 shares Expires 2030-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option has fully vested. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 16:17 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
SaleCommon Stock | 33,333 | $4.09 | $136,465.30 |
DisclosureSEC source: 0001415889-24-017956 · form4-06242024_080648.xml · nonDerivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.185, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 16:17 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionCommon Stock | 33,333 | $1.64 | $54,699.45 |
DisclosureSEC source: 0001415889-24-017956 · form4-06242024_080648.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:39 UTC |
DOUGLAS RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016715 · form4-06132024_090638.xml · derivative · entry 2 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:39 UTC |
DOUGLAS RICHARDDirector
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016715 · form4-06132024_090638.xml · nonDerivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,367 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:31 UTC |
Johnston John JosephDirector
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016709 · form4-06132024_090639.xml · derivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:31 UTC |
Johnston John JosephDirector
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016709 · form4-06132024_090639.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,950 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 17:41 UTC |
Mandell ArtDirector
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016716 · form4-06132024_090602.xml · derivative · entry 2 Mandell Art · CIK 0001874506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 17:41 UTC |
Mandell ArtDirector
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016716 · form4-06132024_090602.xml · nonDerivative · entry 1 Mandell Art · CIK 0001874506 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,851 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:38 UTC |
Hemrajani RekhaDirector
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016713 · form4-06132024_090609.xml · derivative · entry 2 Hemrajani Rekha · CIK 0001771213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:38 UTC |
Hemrajani RekhaDirector
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016713 · form4-06132024_090609.xml · nonDerivative · entry 1 Hemrajani Rekha · CIK 0001771213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,367 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:37 UTC |
Erck Stanley CDirector
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016711 · form4-06132024_090659.xml · derivative · entry 2 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:37 UTC |
Erck Stanley CDirector
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016711 · form4-06132024_090659.xml · nonDerivative · entry 1 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,118 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:32 UTC |
Al-Wakeel Yasir B.Director
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016710 · form4-06132024_090651.xml · derivative · entry 2 Al-Wakeel Yasir B. · CIK 0001650691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:32 UTC |
Al-Wakeel Yasir B.Director
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016710 · form4-06132024_090651.xml · nonDerivative · entry 1 Al-Wakeel Yasir B. · CIK 0001650691 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,367 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:30 UTC |
BALTHROP PATRICK JDirector
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016708 · form4-06132024_090610.xml · derivative · entry 2 BALTHROP PATRICK J · CIK 0001284839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:30 UTC |
BALTHROP PATRICK JDirector
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016708 · form4-06132024_090610.xml · nonDerivative · entry 1 BALTHROP PATRICK J · CIK 0001284839 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,367 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:27 UTC |
Brooke William WDirector
|
GrantStock Option (right to buy) · Derivative | 40,701 | $0.00 Strike: $4.68 | $0.00 |
DisclosureSEC source: 0001415889-24-016706 · form4-06132024_090617.xml · derivative · entry 2 Brooke William W · CIK 0001545337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,701 Underlying: Common Stock · 40,701 shares Expires 2034-06-10 F2 · derivative.exercise_date: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:27 UTC |
Brooke William WDirector
|
GrantCommon Stock | 21,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016706 · form4-06132024_090617.xml · nonDerivative · entry 1 Brooke William W · CIK 0001545337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,669 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · shares: This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 17:55 UTC |
Masoud MaherDirector · President and CEO
|
PurchaseCommon Stock | 70,443 | $4.90 | $345,241.14 |
DisclosureSEC source: 0001415889-24-016259 · form4-06102024_090649.xml · nonDerivative · entry 2 Masoud Maher · CIK 0001874571 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.77 to $5.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 17:55 UTC |
Masoud MaherDirector · President and CEO
|
PurchaseCommon Stock | 29,557 | $4.87 | $143,824.36 |
DisclosureSEC source: 0001415889-24-016259 · form4-06102024_090649.xml · nonDerivative · entry 1 Masoud Maher · CIK 0001874571 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,557 F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.84 to $4.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2024 Filed Mar 28, 2024 20:31 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001415889-24-009334 · form4-03282024_040349.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 617 Underlying: Common Stock · 5,000 shares Expires 2029-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019. Read SEC document |
| March 26, 2024 Filed Mar 28, 2024 20:31 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 5,000 | $4.41 | $22,025.00 |
DisclosureSEC source: 0001415889-24-009334 · form4-03282024_040349.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,583 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.37 to $4.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 26, 2024 Filed Mar 28, 2024 20:31 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 5,000 | $2.14 | $10,710.00 |
DisclosureSEC source: 0001415889-24-009334 · form4-03282024_040349.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:20 UTC |
Sandoval David I.GENERAL COUNSEL
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,625 | $0.00 Strike: $4.31 | $0.00 |
DisclosureSEC source: 0001415889-24-008638 · form4-03192024_100311.xml · derivative · entry 2 Sandoval David I. · CIK 0002012430 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 15,625 shares Expires 2034-03-14 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:20 UTC |
Sandoval David I.GENERAL COUNSEL
|
GrantCommon Stock | 3,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008638 · form4-03192024_100311.xml · nonDerivative · entry 1 Sandoval David I. · CIK 0002012430 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,913 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:21 UTC |
Ross Thomas M.EVP, GLOBAL SALES & MARKETING
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $4.31 | $0.00 |
DisclosureSEC source: 0001415889-24-008640 · form4-03192024_100327.xml · derivative · entry 2 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES & MARKETING 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-03-14 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:21 UTC |
Ross Thomas M.EVP, GLOBAL SALES & MARKETING
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008640 · form4-03192024_100327.xml · nonDerivative · entry 1 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES & MARKETING 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:18 UTC |
Swirsky Douglas JCHIEF FINANCIAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $4.31 | $0.00 |
DisclosureSEC source: 0001415889-24-008636 · form4-03192024_100330.xml · derivative · entry 2 Swirsky Douglas J · CIK 0001375884 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2034-03-14 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 22:18 UTC |
Swirsky Douglas JCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 81,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008636 · form4-03192024_100330.xml · nonDerivative · entry 1 Swirsky Douglas J · CIK 0001375884 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,250 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001415889-24-005727 · form4-02282024_040201.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,617 Underlying: Common Stock · 5,000 shares Expires 2029-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares underlying this option vested monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:30 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 5,000 | $4.60 | $23,005.00 |
DisclosureSEC source: 0001415889-24-005727 · form4-02282024_040201.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,583 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 28, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.51 to $4.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.